Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thromboembolism × Fluorodeoxyglucose F18 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 9 Breast Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Solid Tumor 4 Rectal Neoplasms 4 Neoplasms 3 Lymphoma 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Thromboembolism 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma, Testicular 1 Teratoma 1 Spinal Cord Neoplasms 1 Seminoma 1 Sarcoma, Synovial 1

Interventions

enoxaparin sodium 1 Warfarin 1 Sodium Bicarbonate 1 Saline Solution 1 Pentetic Acid 1 PEGPH20 1 Minocycline 1 Heparin 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Fluoridation 1 Enoxaparin 1 Aspirin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00964275 2014-12-08

MVTEP

University Hospital, Brest

Phase NA Completed

Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡